Article View: sci.med.dentistry
Article #88Re: Lidocaine metabolites immunoactive? (Was: Re: Local anesthetic a carcinogen (Was: Re: Amalgam study))
From: Brian Sandle
Date: Wed, 27 Oct 1999 00:00
Date: Wed, 27 Oct 1999 00:00
31 lines
2570 bytes
2570 bytes
In sci.med.dentistry Brian Sandle <bsandle@southern.co.nz> wrote: : In sci.med.dentistry Brian Sandle <bsandle@southern.co.nz> wrote:: : Carcinogenesis 1994 Oct;15(10):2287-90 : : : : : :2,6-Dimethylaniline--hemoglobin adducts from lidocaine in humans. : : : : : : Bryant MS, Simmons HF, Harrell RE, Hinson JA : [...] : : J Autoimmun 1995 Apr;8(2):293-303 : : : : Autoantibodies to cryptic epitopes of C-reactive protein and other acute : : phase proteins in the toxic oil syndrome. : : : : Bell SA, Du Clos TW, Khursigara G, Picazo JJ, Rubin RL : : : : Toxic oil syndrome (TOS) was caused by the consumption of rapeseed oil : : contaminated with derivatives of aniline. Many persons who survived the : : acute phase developed a puzzling, multi-year chronic disease considered to : : be inflammatory or autoimmune in nature. : [...] : Lidocaine can be immediately a problem for some people. An allergic : reaction occurs. But could there be a longer term problem caused by : aniline metabolites of lidocaine? Now does Lidocaine cross into to embryonic or fetal blood? Do lidocaine metabolites pass over? Does the embryo or fetus have the same risk of allergenicity or aniline toxicity as the mother? What is more dangerous, amalgam or aniline?
Technical Details
Message-ID:
<940984919.119580@mnementh.southern.co.nz>Path:
arc1-ca.pugleaf.net!unknown!not-for-mailReferences:
<379EC3D0.F38A9B67@mail.usyd.edu.au> <37a0a446.34630516@news2.support.nl> <7ntb2m$58m$1@ash.prod.itd.earthlink.net> <37a99d39.104978153@news2.support.nl> <7oaetq$ce3$1@oak.prod.itd.earthlink.net> <kpSs3.1151$7d.1086@nntpserver.swip.net> <934543106.720792@mnementh.southern.co.nz> <940414045.328209@mnementh.southern.co.nz> <940598850.22035@mnementh.southern.co.nz>Show Full Headers
Complete Article Headers
X-Google-Language: ENGLISH,ASCII-7-bit
X-Google-Thread: fd459,e61c7c07cdc3c559
X-Google-Attributes: gidfd459,public
X-Google-Thread: fcb2d,6fa8b7b736d723f8
X-Google-Attributes: gidfcb2d,public
X-Google-Thread: 103efd,6fa8b7b736d723f8
X-Google-Attributes: gid103efd,public
From: Brian Sandle <bsandle@southern.co.nz>
Subject: Re: Lidocaine metabolites immunoactive? (Was: Re: Local anesthetic a carcinogen (Was: Re: Amalgam study))
Date: 1999/10/27
Message-ID: <940984919.119580@mnementh.southern.co.nz>
X-Deja-AN: 540996805
References: <379EC3D0.F38A9B67@mail.usyd.edu.au> <37a0a446.34630516@news2.support.nl> <7ntb2m$58m$1@ash.prod.itd.earthlink.net> <37a99d39.104978153@news2.support.nl> <7oaetq$ce3$1@oak.prod.itd.earthlink.net> <kpSs3.1151$7d.1086@nntpserver.swip.net> <934543106.720792@mnementh.southern.co.nz> <940414045.328209@mnementh.southern.co.nz> <940598850.22035@mnementh.southern.co.nz>
X-Complaints-To: abuse@clear.net.nz
X-Trace: news.clear.net.nz 940984916 202.37.188.6 (Wed, 27 Oct 1999 13:41:56 NZDT)
Organization: Southern Internet Services
User-Agent: tin/pre-1.4-19990216 ("Styrofoam") (UNIX) (SunOS/5.7 (sun4m))
NNTP-Posting-Date: Wed, 27 Oct 1999 13:41:56 NZDT
Newsgroups: sci.med.dentistry,bionet.toxicology,sci.med.immunology